ANTIVIRALE FORMULIERUNGEN

European patent · EP2538946 · In force

Register entry

Publication number
EP2538946
Application number
EP11744202
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 21, 2011
Published
Jan 2, 2013
Granted
Apr 6, 2022
Protection ends at the latest
Feb 20, 2031
Next annual fee due
Feb 28, 2027
IPC classes
A61K 31/737 (2006.01)
A61K 31/351 (2006.01)
A61K 31/215 (2006.01)
A61K 31/04 (2006.01)
A61P 31/14 (2006.01)
A61P 31/16 (2006.01)
A61K 36/04 (2006.01)
A61K 36/03 (2006.01)
A23L 3/3535 (2006.01)
A23L 3/3562 (2006.01)
Priority
US 306910 P 22.02.2010
PCT application
PCT/AU2011/000180 21.02.2011
PCT publication
WO2011/100805 25.08.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  4. Mar 7, 2023

    Change

    Published in Swissreg on 07.03.2023

  5. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  6. Apr 6, 2022

    Granted

    Published in Swissreg on 06.04.2022

Parties

Inventor

FITTON, Helen

Cambridge, Tasmania 7170, AU

GARDINER, Vicki

Cambridge, Tasmania 7170, AU

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.